Form D · Biotechnology

Axelyf, Inc.

Chestnut Hill, MA · CIK 0002078406

Offering snapshot reported Oct 13, 2026 · SEC filing

Reported sold
$2.63M
Offering amount: $2.7M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 7, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2026Initial$2,631,439No comparison8SEC filing
Aug 7, 2025Initial$4,842,133No comparison37SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-600844
Approximately $800,000 of founder-related debt and note conversions are included in 13(a) and 13(b).

Source: Form D, filed Oct 13, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Orn Almarsson Director, Executive, Promoter
Arni Blondal Director
John Lucas Director
Leslie Williams Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
33 Glenland Road Unit 2
Chestnut Hill, MA, 02467
Phone: 508-494-0155